GAMMA Investing’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$46.7K Sell
566
-227
-29% -$20.1K ﹤0.01% 2413
2026
Q2
$76.1K Sell
793
-55
-6% -$5.64K ﹤0.01% 2014
2026
Q1
$92.6K Buy
848
+121
+17% +$11.5K ﹤0.01% 1742
2025
Q4
$59K Buy
727
+179
+33% +$15.4K ﹤0.01% 1957
2025
Q3
$48K Sell
548
-58
-10% -$5.18K ﹤0.01% 2018
2025
Q2
$50.3K Sell
606
-36
-6% -$3.01K ﹤0.01% 1944
2025
Q1
$53.9K Sell
642
-68
-10% -$6.33K ﹤0.01% 1739
2024
Q4
$65.4K Sell
710
-26
-4% -$2.5K 0.01% 1441
2024
Q3
$68.4K Buy
736
+188
+34% +$16.3K 0.01% 1268
2024
Q2
$45.1K Buy
548
+199
+57% +$14.6K 0.01% 1271
2024
Q1
$23.2K Buy
349
+237
+212% +$14.6K ﹤0.01% 1544
2023
Q4
$6.5K Buy
+112
New +$5.87K ﹤0.01% 2112

Other funds holding LMAT

GAMMA Investing's LMAT Position: Q3 2026 in Review

GAMMA Investing reduced its LeMaitre Vascular (LMAT) stake by 29% in Q3 2026, selling an estimated $20.1K and leaving 566 shares worth $46.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2413.

GAMMA Investing first reported a position in LMAT in Q4 2023 and has held it in 12 quarters since. The position peaked at $92.6K in Q1 2026. 7 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.

  • GAMMA Investing held 566 shares of LeMaitre Vascular worth $46.7K as of Q3 2026.
  • GAMMA Investing sold 227 LeMaitre Vascular shares in Q3 2026, an estimated $20.1K.
  • LeMaitre Vascular made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2413 holding.
  • GAMMA Investing first reported a position in LeMaitre Vascular in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's LeMaitre Vascular position peaked at $92.6K in Q1 2026.
  • 7 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.